港股異動 | 股東自願延後解禁限售股 稻草熊娛樂(2125.HK)連續2日大漲
格隆匯7月16日丨稻草熊娛樂(2125.HK)續升超8%,2日累計大漲逾20%,現報7.69港元,暫成交1339萬港元,總市值53億港元。
稻草熊娛樂日前公佈,愛奇藝等股東自願訂立半年禁售期,共涉約71.7%股權,禁售期料至2022年1月11日止。業內人士分析稱,上市公司延後股票解禁期的操作並不少見,但在影視股領域卻是第一次出現,繼獲得2021年影視業開年第一股的稱謂之後,稻草熊“第一”的頭銜再添新章。股東主動延後解禁傳遞出的積極信號,也進一步提振了市場信心,對中小投資者形成利好。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.